{"id":6926,"date":"2025-08-23T13:00:41","date_gmt":"2025-08-23T13:00:41","guid":{"rendered":"https:\/\/autism.fratnow.com\/blog\/?p=6926"},"modified":"2025-08-23T11:43:12","modified_gmt":"2025-08-23T11:43:12","slug":"folate-blocking-vs-binding-autoantibodies","status":"publish","type":"post","link":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/","title":{"rendered":"Folate Blocking vs Binding Autoantibodies"},"content":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8221;6922&#8243; img_size=&#8221;full&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text single_style=&#8221;&#8221;]<\/p>\n<h2>Folate Receptor Blocking Autoantibodies vs. Folate Receptor Binding Autoantibodies<\/h2>\n<p><a href=\"https:\/\/autism.fratnow.com\/blog\/importance-of-vitamin-b9-folate-for-better-brain-development-in-fetuses\/\" target=\"_blank\" rel=\"noopener\">Folate (Vitamin B9)<\/a> is essential for numerous bodily functions, including DNA synthesis, repair, and methylation. Its efficient cellular uptake is primarily mediated by the Folate Receptor Alpha (FR\u03b1). The emergence of autoantibodies against this system is a significant clinical phenomenon, particularly linked to neurodevelopmental disorders like <a href=\"https:\/\/autism.fratnow.com\/blog\/cerebral-folate-deficiency-an-overview\/\" target=\"_blank\" rel=\"noopener\">Cerebral Folate Deficiency (CFD)<\/a> and <a href=\"https:\/\/autism.fratnow.com\/blog\/a-comprehensive-introduction-to-autism-spectrum-disorder\/\" target=\"_blank\" rel=\"noopener\">autism spectrum disorders.<\/a> However, a critical distinction exists between two types of autoantibodies: <strong>Folate Receptor Blocking Autoantibodies<\/strong> and <strong>Folate Binding Autoantibodies.<\/strong> This blog delineates their differences in mechanism, functional impact, clinical consequences, and diagnostic interpretation. The key differentiator is that <strong>folate receptor blocking autoantibodies<\/strong> specifically block the receptor, while <strong>folate receptor binding autoantibodies<\/strong> bind indiscriminately to the folate receptor itself, sequestering it and causing dysfunction of the receptor (often with an inflammatory effect).<\/p>\n<p>To understand the difference, we must first understand the primary pathway of folate transport into critical systems like the central nervous system (CNS):<\/p>\n<ul class=\"mr-left-ol-40-list mr-left-ul-40\">\n<li><strong>Folate Receptor Alpha (FR\u03b1):<\/strong> A high-affinity receptor located on cell membranes, particularly abundant on the choroid plexus (the blood-CSF barrier). It binds folate and facilitates its transport into the brain via endocytosis.<\/li>\n<li><strong>The Problem:<\/strong> Autoantibodies can develop that interfere with this process. Both blocking and binding folate receptor autoantibodies have similar effects in that they derailed proper folate transport into the cell, while the mechanisms of the autoantibodies are different. Both types of autoantibodies are detected in two distinct assays through the FRAT<sup>\u00ae<\/sup> test.<\/li>\n<\/ul>\n<h2>Detailed Comparison Table<\/h2>\n<table class=\"table-section-356325\" style=\"border-collapse: collapse; width: 100%;\">\n<tbody>\n<tr style=\"background-color: #f2f2f2;\">\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Feature<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Folate Receptor Blocking Autoantibodies<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Folate Binding Autoantibodies<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Mechanism of Action<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Bind directly to the folate-binding pocket of FR\u03b1. <strong>Physically block<\/strong> folate from attaching to the receptor.<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Bind indirectly to folate receptor alpha, creating an <strong>immune complex<\/strong>.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Functional Consequence<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Inhibits cellular uptake.<\/strong> Folate cannot enter cells (especially neurons and glial cells) despite normal blood levels. Creates a functional intracellular deficiency.<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Sequesters folate.<\/strong> Renders folate biologically unavailable <em>in circulation.<\/em> Effectively reduces the amount of free, active folate.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Analogous Example<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Blocking a keyhole.<\/strong> The key (folate) is present but cannot fit into the lock (receptor).<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Handcuffing the key.<\/strong> The key (folate) is present but is bound and cannot be used.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Impact on CSF Folate<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Markedly low.<\/strong> The blockade at the choroid plexus prevents transport into the cerebrospinal fluid, leading to Cerebral Folate Deficiency (CSF 5-MTHF &lt; 40 nmol\/L).<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">May be low due to reduced available folate for transport, but the primary defect is not a direct receptor blockade.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Clinical Association<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Strongly linked to CFD<\/strong> and its associated conditions: \u2022 A subset of Autism Spectrum Disorder (ASD) \u2022 Regressive Autism \u2022 Neurological deterioration \u2022 Seizures \u2022 Movement disorders<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Also linked to the same clinical symptoms<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Treatment Implication<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">High-dose <strong>folinic acid<\/strong> (5-formyltetrahydrofolate) can often bypass the blocked receptor via alternative transporters (e.g., Reduced Folate Carrier &#8211; RFC).<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">May require very high doses of folate to saturate and create enough free folate for cellular uptake.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\"><strong>Diagnostic Interpretation<\/strong><\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">The <strong>pathologically significant<\/strong> antibody in the context of neurological CFD. Its presence (especially at high titers) is clinically actionable.<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Same diagnostic interpretation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Folate Receptor Blocking Autoantibodies<\/h2>\n<p><strong>Pathophysiology:<\/strong> Folate Receptor Blocking Autoantibodies are highly specific IgG antibodies that attach to the FR\u03b1 molecule at the exact site where folate is meant to bind. This is a classic example of a <strong>functional blocking antibody<\/strong>. The receptor is present and functional, but its activity is neutralized. This is particularly devastating for tissues that rely almost exclusively on FR\u03b1 for folate uptake, such as the neurons of the developing brain.<\/p>\n<ul>\n<li><strong>Clinical Presentation:<\/strong> The onset of symptoms is often in early childhood (e.g., 2-6 years old). Symptoms are neurological and can include:\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Regression of speech and motor skills<\/li>\n<li>Psychomotor retardation<\/li>\n<li>Seizures<\/li>\n<li>Ataxia and dystonia<\/li>\n<li>Insomnia and irritability<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2>Folate Binding Autoantibodies (FBAAs)<\/h2>\n<ul>\n<li><strong>Pathophysiology<\/strong>: Folate Receptor Binding Autoantibodies bind to an antigenic site not involved in folate binding but can trigger an immune reaction and inflammation and render the receptor nonfunctional. Symptoms are consistent with <strong>systemic folate deficiency<\/strong> and also include:\n<ul class=\"mr-left-ol-40 circle-list mr-left-ul-40\">\n<li>Regression of speech and motor skills<\/li>\n<li>Psychomotor retardation<\/li>\n<li>Seizures<\/li>\n<li>Ataxia and dystonia<\/li>\n<li>Insomnia and irritability<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2>Coexistence of Folate Receptor Autoantibodies<\/h2>\n<p>It is common for patients to test positive for<strong> both<\/strong> types of antibodies. This can present a more complex clinical picture as the synergistic effect may create more of a dysfunction in folate metabolism. Standard blood tests can be misleading, as total serum folate might appear normal. Only the FRAT<sup>\u00ae<\/sup> test will detect the presence of <a href=\"https:\/\/autism.fratnow.com\/blog\/folate-receptor-autoantibodies-in-families-with-autistic-individuals\/\" target=\"_blank\" rel=\"noopener\">folate receptor autoantibodies.<\/a><\/p>\n<h2>Diagnostic Testing<\/h2>\n<p>The most common method for detection of both blocking and binding folate receptor autoantibodies is the FRAT<sup>\u00ae<\/sup> test. Please consult your physician for more information. FRAT<sup>\u00ae<\/sup> requires a physician\u2019s authorization.<\/p>\n<h2>Conclusion and Summary of Key Differences<\/h2>\n<p>While both Folate Receptor Blocking Autoantibodies (FRBAs) and Folate Binding Autoantibodies (FBAAs) disrupt folate metabolism, they are distinct entities with separate mechanisms and primary clinical consequences.<\/p>\n<p>Understanding this critical distinction is essential for clinicians to accurately diagnose the root cause of a patient&#8217;s deficiency and implement the most effective, targeted treatment strategy.<\/p>\n<p><strong>Disclaimer:<\/strong><br \/>\n<em><strong>This blog is for informational purposes only and not medical advice. Consult a healthcare provider for personalized recommendations. The FRAT<sup>\u00ae<\/sup> test is a lab developed test performed in a CLIA certified lab. FRAT<sup>\u00ae<\/sup> is NOT approved by the FDA and requires the authorization of a physician. Please consult your medical professional for more information.<\/strong><\/em>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.<\/p>\n","protected":false},"author":4,"featured_media":6922,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Folate Blocking vs Binding Autoantibodies - fratnow.com<\/title>\n<meta name=\"description\" content=\"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Folate Blocking vs Binding Autoantibodies\" \/>\n<meta property=\"og:description\" content=\"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"fratnow.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/autismfrat\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-23T13:00:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-23T11:43:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/08\/folate-blocking-vs-binding-autoantibodies.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"730\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Steve Tsetsekos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Folate Blocking vs Binding Autoantibodies\" \/>\n<meta name=\"twitter:description\" content=\"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/08\/folate-blocking-vs-binding-autoantibodies.webp\" \/>\n<meta name=\"twitter:creator\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:site\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Tsetsekos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\"},\"author\":{\"name\":\"Steve Tsetsekos\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c\"},\"headline\":\"Folate Blocking vs Binding Autoantibodies\",\"datePublished\":\"2025-08-23T13:00:41+00:00\",\"dateModified\":\"2025-08-23T11:43:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\"},\"wordCount\":907,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"articleSection\":[\"Neurodiversity &amp; Wellbeing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\",\"name\":\"Folate Blocking vs Binding Autoantibodies - fratnow.com\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\"},\"datePublished\":\"2025-08-23T13:00:41+00:00\",\"dateModified\":\"2025-08-23T11:43:12+00:00\",\"description\":\"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.\",\"breadcrumb\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/autism.fratnow.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Folate Blocking vs Binding Autoantibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"name\":\"fratnow.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\",\"name\":\"fratnow.com\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"width\":194,\"height\":66,\"caption\":\"fratnow.com\"},\"image\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/autismfrat\",\"https:\/\/twitter.com\/AutismFrat\",\"https:\/\/www.linkedin.com\/company\/88011685\/admin\/\",\"https:\/\/www.instagram.com\/fratautism\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c\",\"name\":\"Steve Tsetsekos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"caption\":\"Steve Tsetsekos\"},\"sameAs\":[\"https:\/\/autism.fratnow.com\/blog\/\"],\"url\":\"https:\/\/autism.fratnow.com\/blog\/author\/steve-tsetsekos\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Folate Blocking vs Binding Autoantibodies - fratnow.com","description":"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/","og_locale":"en_US","og_type":"article","og_title":"Folate Blocking vs Binding Autoantibodies","og_description":"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.","og_url":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/","og_site_name":"fratnow.com","article_publisher":"https:\/\/www.facebook.com\/autismfrat","article_published_time":"2025-08-23T13:00:41+00:00","article_modified_time":"2025-08-23T11:43:12+00:00","og_image":[{"width":730,"height":400,"url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/08\/folate-blocking-vs-binding-autoantibodies.webp","type":"image\/webp"}],"author":"Steve Tsetsekos","twitter_card":"summary_large_image","twitter_title":"Folate Blocking vs Binding Autoantibodies","twitter_description":"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.","twitter_image":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/08\/folate-blocking-vs-binding-autoantibodies.webp","twitter_creator":"@AutismFrat","twitter_site":"@AutismFrat","twitter_misc":{"Written by":"Steve Tsetsekos","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#article","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/"},"author":{"name":"Steve Tsetsekos","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c"},"headline":"Folate Blocking vs Binding Autoantibodies","datePublished":"2025-08-23T13:00:41+00:00","dateModified":"2025-08-23T11:43:12+00:00","mainEntityOfPage":{"@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/"},"wordCount":907,"commentCount":0,"publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"articleSection":["Neurodiversity &amp; Wellbeing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/","url":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/","name":"Folate Blocking vs Binding Autoantibodies - fratnow.com","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/#website"},"datePublished":"2025-08-23T13:00:41+00:00","dateModified":"2025-08-23T11:43:12+00:00","description":"Learn how folate receptor blocking and binding autoantibodies disrupt folate transport, cause cerebral folate deficiency, and affect neurodevelopment.","breadcrumb":{"@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/autism.fratnow.com\/blog\/folate-blocking-vs-binding-autoantibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/autism.fratnow.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Folate Blocking vs Binding Autoantibodies"}]},{"@type":"WebSite","@id":"https:\/\/autism.fratnow.com\/blog\/#website","url":"https:\/\/autism.fratnow.com\/blog\/","name":"fratnow.com","description":"","publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/autism.fratnow.com\/blog\/#organization","name":"fratnow.com","url":"https:\/\/autism.fratnow.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","width":194,"height":66,"caption":"fratnow.com"},"image":{"@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/autismfrat","https:\/\/twitter.com\/AutismFrat","https:\/\/www.linkedin.com\/company\/88011685\/admin\/","https:\/\/www.instagram.com\/fratautism\/"]},{"@type":"Person","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c","name":"Steve Tsetsekos","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","caption":"Steve Tsetsekos"},"sameAs":["https:\/\/autism.fratnow.com\/blog\/"],"url":"https:\/\/autism.fratnow.com\/blog\/author\/steve-tsetsekos\/"}]}},"_links":{"self":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6926"}],"collection":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/comments?post=6926"}],"version-history":[{"count":3,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6926\/revisions"}],"predecessor-version":[{"id":6929,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/6926\/revisions\/6929"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media\/6922"}],"wp:attachment":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media?parent=6926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/categories?post=6926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/tags?post=6926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}